CRF receptor blockade prevents initiation and consolidation of stress effects on affect in the predator stress model of PTSD

International Journal of Neuropsychopharmacology

Volumn 13, Issue 6, 2010, Pages 747-757

  Adamec, Robert ^a   Fougere, Dennis ^b   Risbrough, Victoria ^c  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b UNIVERSITY OF NEW BRUNSWICK   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anxiety; consolidation; CRF1; initiation; predator stress; PTSD

Indexed keywords

CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CRA 0450; UNCLASSIFIED DRUG; 1-(8-(2,4-DICHLOROPHENYL)-2-METHYLQUINOLIN-4-YL)-1,2,3,6-TETRAHYDROPYRIDINE-4-CARBOXAMIDE BENZENESULFONATE; BENZENESULFONIC ACID DERIVATIVE; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; QUINOLINE DERIVATIVE;

AMPLITUDE MODULATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; AROUSAL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; HABITUATION; LIGHT DARK CYCLE; MALE; MAZE TEST; MOUSE; NONHUMAN; POSTTRAUMATIC STRESS DISORDER; PREDATOR STRESS; PRIORITY JOURNAL; PROPHYLAXIS; RISK ASSESSMENT; RODENT; STARTLE REFLEX; TRANQUILIZING ACTIVITY; ANALYSIS OF VARIANCE; ANIMAL; ANIMAL BEHAVIOR; ANTAGONISTS AND INHIBITORS; AUDITORY STIMULATION; C57BL MOUSE; CAT; COMPLICATION; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; MENTAL STRESS; METABOLISM; RANDOMIZATION; REACTION TIME; STRESS DISORDERS, POST-TRAUMATIC; TIME; VISUAL ADAPTATION;

ACOUSTIC STIMULATION; ADAPTATION, OCULAR; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; BENZENESULFONATES; CATS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; QUINOLINES; RANDOM ALLOCATION; REACTION TIME; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; STARTLE REACTION; STRESS DISORDERS, POST-TRAUMATIC; STRESS, PSYCHOLOGICAL; TIME FACTORS; REFLEX, STARTLE;

EID: 77957107113     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145709990496     Document Type: Article

References (62)

1. Adamec R (1997). Transmitter systems involved in neural plasticity underlying increased anxiety and defense - implications for understanding anxiety following traumatic stress. Neuroscience and Biobehavioral Reviews 21, 755-765.
2. Adamec R, Bartoszyk GD, Burton P (2004a). Effects of systemic injections of Vilazodone, a selective serotonin reuptake inhibitor and serotonin 1A receptor agonist, on anxiety induced by predator stress in rats. European Journal of Pharmacology 504, 65-77. (Pubitemid 39410725)
3. Adamec R, Blundell J, Burton P (2005a). Role of NMDA receptors in the lateralized potentiation of amygdala afferent and efferent neural transmission produced by predator stress. Physiology and Behavior 86, 75-91.
4. Adamec R, Blundell J, Strasser K, Burton P (2006a). Mechanisms of lasting change in anxiety induced by severe stress. In: Sato N, Pitman R (Eds), PTSD: Brain Mechanisms and Clinical Implications (pp. 61-81). Tokyo: Springer-Verlag.
5. Adamec R, Burton P, Blundell J, Murphy DL, Holmes A (2006c). Vulnerability to mild predator stress in serotonin transporter knockout mice. Behavioural Brain Research 170, 126-140.
6. Adamec R, Creamer K, Bartoszyk GD, Burton P (2004b). Prophylactic and therapeutic effects of acute systemic injections ofEMD 281014, a selective serotonin 2A receptor antagonist on anxiety induced by predator stress in rats. European Journal of Pharmacology 504, 79-96. (Pubitemid 39410726)
7. Adamec R, Head D, Blundell J, Burton P, Berton O (2006d). Lasting anxiogenic effects of feline predator stress in mice: sex differences in vulnerability to stress and predicting severity of anxiogenic response from the stress experience. Physiology and Behavior 88, 12-29.
8. Adamec R, Head D, Soreq H, Blundell J (2008a). The role of the read through variant of acetylcholinesterase in anxiogenic effects of predator stress in mice. Behavioural Brain Research 189, 180-190.
9. Adamec R, Holmes A, Blundell J (2008b). Vulnerability to lasting anxiogenic effects of brief exposure to predator stimuli: sex, serotonin and other factors - relevance to PTSD. Neuroscience and Biobehavioral Reviews 32, 1287-1292.
10. Adamec R, Kent P, Anisman H, Shallow T, Merali Z (1998). Neural plasticity, neuropeptides and anxiety in animals - implications for understanding and treating affective disorder following traumatic stress in humans. Neuroscience and Biobehavioral Reviews 23, 301-318.
11. Adamec R, Muir C, Grimes M, Pearcey K (2007). Involvement of noradrenergic and corticoid receptors in the consolidation of the lasting anxiogenic effects of predator stress. Behavioural Brain Research 179, 192-207.
12. Adamec R, Strasser K, Blundell J, Burton P, McKay DW (2006b). Protein synthesis and the mechanisms of lasting change in anxiety induced by severe stress. Behavioural Brain Research 167, 270-286.
13. Adamec R, Walling S, Burton P (2004c). Long-lasting, selective, anxiogenic effects of feline predator stress in mice. Physiology and Behavior 80, 401-410.
14. Adamec RE, Blundell J, Burton P (2005b). Neural circuit changes mediating lasting brain and behavioral response to predator stress. Neuroscience and Biobehavioral Reviews 29, 1225-1241.
15. Adamec RE, Burton P, Shallow T, Budgell J (1999a). NMDA receptors mediate lasting increases in anxiety-like behavior produced by the stress of predator exposure - implications for anxiety associated with posttraumatic stress disorder. Physiology and Behavior 65, 723-737.
16. Adamec RE, Burton P, Shallow T, Budgell J (1999b). Unilateral block of NMDA receptors in the amygdala prevents predator stress-induced lasting increases in anxiety-like behavior and unconditioned startle - effect on behavior depends on the hemisphere. Physiology and Behavior 65, 739-751.
17. Adamec RE, Shallow T (1993). Lasting effects on rodent anxiety of a single exposure to a cat. Physiology and Behavior 54, 101-109.
18. APA (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Association.
19. Baker DG, West SA, Nicholson WE, Ekhator NN, et al. (1999). Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder. American Journal of Psychiatry 156, 585-588.
20. Bakshi VP, Smith-Roe S, Newman SM, Grigoriadis DE, Kalin NH (2002). Reduction of stress-induced behavior by antagonism of corticotropin-releasing hormone 2 (CRH2) receptors in lateral septum or CRH1 receptors in amygdala. Journal of Neuroscience 22, 2926-2935.
21. Blundell J, Adamec R (2007). The NMDA receptor antagonist CPP blocks the effects of predator stress on pCREB in brain regions involved in fearful and anxious behavior. Brain Research 1136, 59-76.
22. Blundell J, Adamec R, Burton P (2005). Role of NMDA receptors in the syndrome of behavioral changes produced by predator stress. Physiology and Behavior 86, 233-243.
23. Caspi A, Sugden K, Moffitt TE, Taylor A, et al. (2003). Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301, 386-389.
24. Chaki S, Nakazato A, Kennis L, Nakamura M, et al. (2004). Anxiolytic- and antidepressant-like profile of a new CRF1 receptor antagonist, R278995/CRA0450. European Journal of Pharmacology 485, 145-158.
25. Cohen H, Kaplan Z, Matar MA, Loewenthal U, et al. (2006). Anisomycin, a protein synthesis inhibitor, disrupts traumatic memory consolidation and attenuates posttraumatic stress response in rats. Biological Psychiatry 60, 767-776.
26. Cohen H, Zohar J, Matar MA, Zeev K, et al. (2004). Setting apart the affected: the use of behavioral criteria in animal models of post traumatic stress disorder. Neuropsychopharmacology 29, 1962-1970.
27. Contarino A, Dellu F, Koob GF, Smith GW, et al. (1999). Reduced anxiety-like and cognitive performance in mice lacking the corticotropin- releasing factor receptor 1. Brain Research 835, 1-9.
28. Crabbe JC, Wahlsten D, Dudek BC (1999). Genetics of mouse behavior: interactions with laboratory environment. Science 284, 1670-1672.
29. File SE (1987). The contribution of behavioural studies to the neuropharmacology of anxiety. Neuropharmacology 26, 877-886.
30. Griebel G, Perrault G, Sanger DJ (1998). Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone. Psychopharmacology (Berlin) 138, 55-66.
31. Grillon C, Pine DS, Lissek S, Rabin S, Vythilingam M (2009). Increased anxiety during anticipation of unpredictable aversive stimuli in posttraumatic stress disorder but not in generalized anxiety disorder. Biological Psychiatry 66, 47-53.
32. Groenink L, Pattij T, de JR, van der GJ, et al. (2003). 5-HT1A receptor knockout mice and mice overexpressing corticotropin-releasing hormone in models of anxiety. European Journal of Pharmacology 463, 185-197.
33. Hauger RL, Risbrough V, Brauns O, Dautzenberg FM (2006). Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets. CNS and Neurological Disorders - Drug Targets 5, 453-479.
34. Hebb ALO, Zacharko RM, Dominguez H, Laforest S, et al. (2003). Changes in brain cholecystokinin and anxiety-like behavior following exposure of mice to predator odor. Neuroscience 116, 539-551.
35. Heim C, Newport DJ, Heit S, Graham YP, et al. (2000). Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. Journal of the American Medical Association 284, 592-597.
36. Heim C, Owens MJ, Plotsky PM, Nemeroff CB (1997). The role of early adverse life events in the etiology of depression and posttraumatic stress disorder - focus on corticotropin-releasing factor. Annals of the New York Academy of Sciences 821, 194-207.
37. Henry B, Vale W, Markou A (2006). The effect of lateral septum corticotropin-releasing factor receptor 2 activation on anxiety is modulated by stress. Journal of Neuroscience 26, 9142-9152.
38. Institute of Medicine (2007). Treatment of Posttraumatic Stress Disorder: An Assessment of the Evidence. Washington, DC: The National Academies Press.
39. Kaplan NM (1992). The adrenal glands. In: Griffen JE, Ojeda, SR (Eds), Textbook of Endocrine Physiology (pp. 247-275). New York: Oxford University Press.
40. Kessler RC, Berglund P, Demler O, Jin R, et al. (2005). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry 62, 593-602. (Pubitemid 40973434)
41. Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB (1995). Posttraumatic stress disorder in the National Comorbidity Survey. Archives of General Psychiatry 52, 1048-1060.
42. Nemeroff CB, Bremner JD, Foa EB, Mayberg HS, et al. (2006). Posttraumatic stress disorder: a state-of-the-science review. Journal of Psychiatric Research 40, 1-21.
43. Okuyama S, Chaki S, Kawashima N, Suzuki Y, et al. (1999). Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001. Journal of Pharmacology and Experimental Therapeutics 289, 926-935.
44. Orr SP, Metzger LJ, Pitman RK (2002). Psychophysiology of post-traumatic stress disorder. Psychiatric Clinics of North America 25, 271-293.
45. Rainnie DG, Bergeron R, Sajdyk TJ, Patil M, et al. (2004). Corticotrophin releasing factor-induced synaptic plasticity in the amygdala translates stress into emotional disorders. Journal of Neuroscience 24, 3471-3479.
46. Rauch SL, Shin LM, Phelps EA (2006). Neurocircuitry models of posttraumatic stress disorder and extinction: human neuroimaging research - past, present, and future. Biological Psychiatry 60, 376-382.
47. Risbrough VB, Geyer MA, Hauger RL, Coste S, et al. (2009). CRF(1) and CRF(2) receptors are required for potentiated startle to contextual but not discrete cues. Neuropsychopharmacology 36, 1494-1503.
48. Risbrough VB, Hauger RL, Pelleymounter MA, Geyer MA (2003). Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice. Psychopharmacology 170, 178-187.
49. Risbrough VB, Hauger RL, Roberts AL, Vale WW, Geyer MA (2004). Corticotropin releasing factor receptors CRF1 and CRF2 exert both additive and opposing influences on defensive startle behavior. Journal of Neuroscience 24, 6545-6552.
50. Risbrough VB, Stein MB (2006). Role of corticotropin releasing factor in anxiety disorders: a translational research perspective. Hormones and Behavior 50, 550-561.
51. Sautter FJ, Bissette G, Wiley J, Manguno-Mire G, et al. (2003). Corticotropin-releasing factor in posttraurnatic stress disorder (PTSD) with secondary psychotic symptoms, nonpsychotic PTSD, and healthy control subjects. Biological Psychiatry 54, 1382-1388.
52. Shekhar A, Truitt W, Rainnie D, Sajdyk T (2005). Role of stress, corticotrophin releasing factor (CRF) and amygdala plasticity in chronic anxiety. Stress 8, 209-219.
53. Silver RC, Holman EA, McIntosh DN, Poulin M, Gil-Rivas V (2002). Nationwide longitudinal study of psychological responses to September 11. Journal of the American Medical Association 288, 1235-1244.
54. Smith GW, Aubry JM, Dellu F, Contarino A, et al. (1998). Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 20, 1093-1102.
55. Stam R (2007). PTSD and stress sensitisation: a tale of brain and body. Part 1: human studies. Neuroscience and Biobehavioral Reviews 31, 530-557. (Pubitemid 46527881)
56. Steckler T, Dautzenberg FM (2006). Corticotropin-releasing factor receptor antagonists in affective disorders and drug dependence - an update. CNS and Neurological Disorders - Drug Targets 5, 147-165.
57. Stenzel-Poore MP, Heinrichs SC, Rivest S, Koob GF, Vale WW (1994). Overproduction of corticotropinreleasing factor in transgenic mice: a genetic model of anxiogenic behavior. Journal of Neuroscience 14, 2579-2584.
58. Timpl P, Spanagel R, Sillaber I, Kresse A, et al. (1998). Impaired stress response and reduced anxiety in mice lacking a functional corticotropin- releasing hormone receptor 1. Nature Genetics 19, 162-166.
59. Todorovic C, Radulovic J, Jahn O, RadulovicM, et al. (2007). Differential activation of CRF receptor subtypes removes stress-induced memory deficit and anxiety. European Journal of Neuroscience 25, 3385-3397.
60. Ugolini A, Sokal DM, Arban R, Large CH (2008). CRF1 receptor activation increases the response of neurons in the basolateral nucleus of the amygdala to afferent stimulation. Frontiers in Behavioral Neuroscience 2, 2.
61. Yehuda R (2002). Post-traumatic stress disorder. New England Journal of Medicine 346, 108-114.
62. Zoladz PR, Conrad CD, Fleshner M, Diamond DM (2008). Acute episodes of predator exposure in conjunction with chronic social instability as an animal model of post-traumatic stress disorder. Stress 11, 259-281.